GERMANY – EW Nutrition, a leading provider of animal nutrition solutions to the feed industry, has announced the launch of its innovative new thermostable xylanase product, Axxess XY, during the prestigious VICTAM Asia 2024 exhibition held at the BITEC Exhibition Center in Bangkok.
Axxess XY represents a significant breakthrough in enzyme technology, offering feed producers a cutting-edge solution to enhance feed efficiency and optimize animal nutrition.
This intrinsically thermostable xylanase is designed to break down both the soluble and insoluble fiber fractions found in a variety of feed ingredients, including corn, wheat, grain by-products, and oilseed cakes.
By releasing trapped nutrients within cell wall fractions and improving the gut environment through viscosity reduction, Axxess XY empowers feed producers with greater flexibility in feed formulation and substantial cost savings.
Ramakanta Nayak, Regional Director for EW Nutrition South East Asia/Pacific, emphasized the company’s dedication to addressing the evolving needs of animal production and contributing to the growth of the industry in the region.
“The successful launch of Axxess XY at VICTAM Asia 2024 demonstrates our commitment to providing cutting-edge solutions,” Nayak stated.
Dr. Ajay Awati, Global Director of Enzymes at EW Nutrition, expressed his excitement about the positive response to Axxess XY, highlighting the tireless efforts of the EW Nutrition R&D team in pushing the boundaries of enzyme technology in animal nutrition.
“Axxess XY is the result of our team’s hard work and dedication,” Dr. Awati affirmed.
With its advanced features and unparalleled efficacy, Axxess XY is poised to revolutionize the enzyme market, solidifying EW Nutrition’s position as a key player in the industry.
In related news, EW Nutrition recently announced the acquisition of the Biomin BioStabil silage inoculant product line from dsm-Firmenich to further bolster its presence in the animal nutrition sector.
The deal marks a significant expansion for EW Nutrition, granting ownership of a well-established and successful line of silage inoculants.
Jan Vanbrabant, CEO of EW Nutrition, expressed enthusiasm about the acquisition, stating, “The agreement we have concluded gives us a solid foothold in a sector where we are currently developing a more substantial presence. EW Nutrition continues to expand strategically, enriching its portfolio with market-leading solutions, developed in-house or through acquisitions.”
For all the latest food safety news from Africa and the World, subscribe to our NEWSLETTER, follow us on Twitter and LinkedIn, like us on Facebook, and subscribe to our YouTube channel.
